Vaxart (VXRT)

• Market cap: $84.7M
• 1 day: -8.48%
• 5 days: -22.40%
• 1 month: -21.11%
• 3 months: -48.17%
• 6 months: -54.74%
• Year to date: -48.17%
• 1 year: -71.35%
• 5 years: -78.47%
• 10 years: -97.92%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

15% more call options, than puts

Call options by funds: $133K | Put options by funds: $116K

0.81% less ownership

Funds ownership: 16.52% [Q3] → 15.71% (-0.81%) [Q4]

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

7% less funds holding

Funds holding: 99 [Q3] → 92 (-7) [Q4]

26% less capital invested

Capital invested by funds: $31.9M [Q3] → $23.7M (-$8.23M) [Q4]

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2 437% upside
• Avg. target: $2 437% upside
• High target: $2 437% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

B. Riley Securities Mayank Mamtani 14% 1-year accuracy 3 / 22 met price target

437% upside $2

Buy Maintained

27 Mar 2025